Literatur
Duncan MS et al. Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease. JAMA. 2019;322(7):642-50
Winsvold BS et al. Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor. Ann Neurol. 2023;94(4):713-26
Rozen TD. Cluster Headache Clinical Phenotypes: Tobacco Nonexposed (Never Smoker and No Parental Secondary Smoke Exposure as a Child) versus Tobacco-Exposed: Results from the United States Cluster Headache Survey. Headache. 2018;58(5):688-99
Rozen TD. Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study. Cephalalgia. 2023;43(10):3331024231208679
Holle D et al. Influences of smoking and caffeine consumption on trigeminal pain processing. J Headache Pain. 2014;15(1):39
Rozen TD et al. Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache. 2012;52(1):99-113
Villalón CM, Centurión D. Cardiovascular responses produced by 5-hydroxytriptamine. Naunyn Schmiedebergs Arch Pharmacol. 2007;376(1-2):45-63
Saxena PR. Cardiovascular effects from stimulation of 5-hydroxytryptamine receptors. Fundam Clin Pharmacol. 1989;3(3):245-65
Glennon RA. Serotonin receptors: clinical implications. Neurosci Biobehav Rev. 1990;14(1):35-47
Vikenes K et al. Serotonin is associated with coronary artery disease and cardiac events. Circulation. 1999;100(5):483-9
Dodick D et al. Cardiovascular Safety of Triptans. Cephalalgia. 2004;24(7):513
Newman CM et al. Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries. Eur J Clin Pharmacol. 2005;61(10):733-42
MaassenVanDenBrink A et al. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 1998;98(1):25-30
Tansey MJ et al. Long-term experience with sumatriptan in the treatment of migraine. Eur Neurol. 1993;33(4):310-5
Géraud G et al. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-912028325
Göbel H et al. Acute therapy for cluster headache with sumatriptan. Neurology. 1998;51(3):908-11
Siow H et al. Frovatriptan for the Treatment of Cluster Headaches. Cephalalgia. 2004;24(12):1045-1048
Diener HC et al. Therapie der Migräneattacke und Prophylaxe der Migräne, S1-Leitlinie, 2022, DGN und DMKG, in: Deutsche Gesellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therapie in der Neurologie. www.dgn.org/leitlinien (Zugriff am 17.03.2024)
Lund NLT et al. Current treatment options for cluster headache: limitations and the unmet need for better and specific treatments-a consensus article. J Headache Pain. 2023;24(1):121
Cirillo M et al. Headache and cardiovascular risk factors: positive association with hypertension. Headache. 1999;39(6):409-16
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scheytt, B. Erst Clusterkopfschmerzen, dann der Myokardinfarkt - ein Fallbericht. Schmerzmed. 40, 58–61 (2024). https://doi.org/10.1007/s00940-024-4705-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00940-024-4705-8